Dotbee.ai

Analysis DSM-Firmenich AG (0AC9)

5/30/2024

Analysis DSM-Firmenich AG (0AC9)

Analysis of DSM-Firmenich AG (0AC9)

DSM-Firmenich AG is showing some interesting trends based on the provided data.

- The closing prices have been fluctuating, with the latest closing price at 107.40885.
- The Relative Strength Index (RSI) is indicating a slightly bearish sentiment at 58.11706, suggesting a potential reversal in the current trend.
- The Moving Average Convergence Divergence (MACD) indicator is positive at 0.85312, with the signal line at 0.67248, indicating a bullish signal.
- The Moving Average (MA) indicator is at 104.46892, which is below the latest closing price, suggesting a potential uptrend.

Overall, based on the RSI and MA indicators, there might be a short-term bearish sentiment, but the MACD indicator is showing a bullish signal. Traders and investors should closely monitor these indicators to make informed decisions regarding DSM-Firmenich AG.

Earnings

The company's results for the most recent quarter ending on April 30, 2025, have not been provided at this time. The previous results were reported on February 27, 2025, through the Transfer Agent. Before that, on January 31, 2025, the results were released after hours. The results for October 31, 2024, were not provided at the time. On August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.

Main Statystic 🧠

The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.

In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and the most recent quarter reported is March 2024. The company shows good returns on assets and equity.

Looking at stock statistics, the short ratio is low, and a significant portion of shares is held by institutions. The stock price has a beta of 1.264 and has shown a slight increase over the fifty-two week period.

Valuation metrics show a high PEG ratio and price to book ratio, with the stock trading at a relatively high forward PE ratio. The company's market capitalization and enterprise value are substantial, with moderate ratios for enterprise to EBITDA and revenue.

The stock price summary indicates the stock's performance over the past year, with a range between the fifty-two week low and high prices.

Lastly, the dividends and splits information shows the company's dividend history, payout ratio, and upcoming dividend dates. The company has a history of dividend payments and a moderate dividend yield.

Income statement 💸

Here are the revenue figures for the company over the past four fiscal years:

1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000

From these figures, we can observe the following trends:
- The company experienced a decrease in revenue from FY 2022 to FY 2023.
- Prior to FY 2023, there was a general trend of increasing revenue over the years.
- The highest revenue was recorded in FY 2022.

These trends can provide insights into the company's performance and market conditions over the specified period.

Balance Sheet

These are balance sheets. Here are the conclusions:

1. The total assets have been increasing over the years, reaching the highest value of $365,725,000,000 in 2018.
2. The current assets have fluctuated, with the highest value of $162,819,000,000 in 2019.
3. Cash and cash equivalents have varied, with the peak value of $48,844,000,000 in 2019.
4. Non-current assets have generally been increasing, with the highest value of $234,386,000,000 in 2018.
5. Total liabilities have also been increasing, reaching the highest value of $302,083,000,000 in 2022.
6. Shareholders' equity has shown fluctuations, with the highest value of $107,147,000,000 in 2018.
7. Retained earnings have been negative in some years, indicating losses or dividend payments exceeding profits.
8. The company has been relying on debt financing, as seen in the increasing long-term debt over the years.
9. The company has been investing in non-current assets, such as investments and advances, which have been increasing steadily.
10. The provision for risks and charges has also been increasing, indicating a focus on risk management.

Cash Flow 💶

Based on the cash flow data provided, we can draw the following conclusions:

1. The company's free cash flow has been fluctuating over the years, with a significant increase in 2022 compared to 2021 and a slight decrease in 2023 compared to 2022.

2. The company has been consistently paying interest and income taxes, with varying amounts each year.

3. The end cash position has been fluctuating, showing a general increasing trend over the years.

4. Financing activities have had a significant impact on the company's cash flow, with large amounts being used for common stock repurchase and long-term debt issuance.

5. Investing activities also play a significant role, with the company making investments through acquisitions and the purchase of investments.

6. Operating activities have generated positive cash flow each year, with net income being a major contributor along with depreciation and stock-based compensation.

7. Overall, the company's cash flow statement reflects a mix of financing, investing, and operating activities that have influenced its cash position and financial performance over the years.

Earnings estimate

The analysts' estimates for future quarterly and annual earnings per share are as follows:

1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26

2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25

3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39

4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39

Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and the next two years. The average estimates show an increase compared to the year-ago EPS figures, indicating potential growth in earnings for the company. It's important to note that these are analyst projections and actual results may vary.

Revenue estimate

Based on analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:

1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.

2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.

3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.

4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.

These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year.

Growth estimates

Based on the consensus estimates provided:
- The company is expected to have a growth rate of 7.5% in the current year.
- The growth rate is projected to increase to 5.6% in the current quarter and further to 4.8% in the next quarter.
- Over the next year, the growth rate is expected to reach 9.7%.
- The company is forecasted to have an annual growth rate of 11% over the next 5 years.
- In the past 5 years, the company had a higher annual growth rate of approximately 20.1%.

Overall, the company is expected to experience steady growth in the upcoming periods, with a significant increase in growth rate compared to the past 5 years.

Price target

The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD

Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the lowest estimate at $164, the highest at $250, and the average at $202.26. The current price is $191.57, which is below the average and median forecasted prices. Investors should consider these forecasts along with other factors when making investment decisions.

MACD of 0AC9

This is not investment advice. Remember to verify the information provided here.

Get access to the full analysis

  • Over 35 000 indexes
  • CFD, Forex, Crypto and Stocks Exchange
  • Over 150 Indicators
  • Pattern and candle analysis
  • Support and resistance levels
  • Fundamental, technical and sentimental analysis
  • Power from AI
Web versionApp StoreGoogle Play

Contacts

Telephone number

+48 32 700 81 66

Email address

[email protected]

Company information

Honey Payment Group S.A. at Al. Aleje Jerozolimskie 65 / 79, 00-697 Warsaw, Poland, Register number KRS 0000335507, NIP 5252859204, REGON 388760204. Honey Payment Group is listed on the Warsaw Stock Exchange (WSE) under the ticker symbol HPG. Link